TABLE 2.

Inoculation schedule and inoculum type for 28 animals^a

Animal ID	Inoculum		Stock type	Dose		Route
	SHIV strain	Position 375 variant(s)		ng of p27 used for each variant	Total ng of p27 used for each animal
RM196	SHIV 191859	S and M	293T	250	1,000	i.r.
	SHIV 191859 gp41	S and M
RM194	SHIV 191859	S and M	293T	250	2,000	i.r.
	SHIV 191859 gp41	S and M
RM131	SHIV 191859	S, M, H, Y, F, and W	293T	166	1,000	i.v.
RM138	SHIV 191859	S, M, H, Y, F, and W	293T	166	1,000	i.v.
RM6434	SHIV BG505 332N	S, M, H, Y, F, and W	293T	50	300	i.v.
RM6442	SHIV BG505 332N	S, M, H, Y, F, and W	293T	50	300	i.v.
RM6446	SHIV BG505 332T	S, M, H, Y, F, and W	293T	50	300	i.v.
RM6454	SHIV BG505 332N	S, M, H, Y, F, and W	293T	50	600	i.v.
	SHIV BG505 332T	S, M, H, Y, F, and W
RM43335	SHIV BG505 332N	S, M, H, Y, F, and W	293T	50	600	i.v.
	SHIV BG505 332T	S, M, H, Y, F, and W
RM6718	SHIV BG505 332N	Y	RhCD4+ T cells	8	8	i.r.
RM6719	SHIV BG505 332N	Y	RhCD4+ T cells	8	8	i.r.
RMT283	SHIV BG505 332N	Y	RhCD4+ T cells	1.5	1.5	i.r.
RM6715	SHIV BG505 332N	Y	RhCD4+ T cells	8	8	i.r.
RM6706	SHIV BG505 332N	Y	RhCD4+ T cells	1.5	1.5	i.r.
RM6708	SHIV BG505 332N	Y	RhCD4+ T cells	1.5	1.5	i.r.
RM6717	SHIV BG505 332N	Y	RhCD4+ T cells	8	8	i.r.
RM08N021	SHIV BG505 332N	Y	RhCD4+ T cells	1	1	i.r.
RM10N011	SHIV BG505 332N	Y	RhCD4+ T cells	1	1	i.r.
RM6072	SHIV CH505	S, M, H, Y, F, and W	293T	500	3,000	i.v.
RM5694	SHIV CH505	H in 3 different backbones	293T	5	15	i.v.
RMT775	SHIV CH505	H in 3 different backbones	293T	5	15	i.v.
RMT943	SHIV CH848 1017	H	293T	50	100	i.v.
	SHIV CH848 1017DT	H
RMT944	SHIV CH848 1017	H	293T	50	100	i.v.
	SHIV CH848 1017DT	H
RMT945	SHIV CH848 1017	H	293T	50	100	i.v.
	SHIV CH848 1017DT	H
RMT682	SHIV 1086	S, M, H, Y, F, and W	293T	50	300	i.v.
RMT929	SHIV 1086	W	293T	50	50	i.v.
RMT930	SHIV 1086	W	293T	50	50	i.v.
RM41216	SHIV 40100	S, M, H, Y, F, and W	293T	50	300	i.v.

^aThe inocula for RM5694 and RMT775 were identical in env gp160 sequence. i.r., intrarectal; i.v., intravenous.